MITA News

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today applauded Senate Finance Committee Chairman Sen. Max Baucus (D-Mont.), Ranking Member Sen. Orrin Hatch (R-Utah), House Ways & Means Committee Chairman Rep. Dave Camp (R-Mich.), Ranking Member Rep. Sander Levin (D-Mich.), House Energy and Commerce Chairman Rep. Fred Upton (R-Mich.) and Ranking Member Rep. Henry Waxman (D-Calif.) for their leadership in developing a bipartisan Medicare payment reform package to permanently repeal the broken sustainable growth rate (SGR) formula.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today said that Rita Redberg and Rebecca Smith-Bindman’s New York Times op-ed disregards current evidence that documents the success of advanced medical imaging technologies and unfortunately overlooks the rigorous initiatives spearheaded by the medical imaging community to address radiation dose.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today said a new report reaffirms that utilization of advanced medical imaging services is declining and should discourage additional Medicare reimbursement cuts and other obstacles that could further impede patient access. The report indicates that the number of computed tomography (CT) procedures performed in the United States has declined at an average annual rate of 5.5 percent over the past two years.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today applauded Congressional leaders for agreeing on a $1.1 trillion omnibus spending package that will fund the federal government through the end of September 2014, increase funding for the Food and Drug Administration (FDA), and restore $85 million in funding lost last year due to the sequestration of FDA user fees. Since sequestration cuts went into effect in March 2013, the FDA has not had access to the full amount of the user fees submitted by manufacturers with their medical device applications, which help improve the efficiency and predictability of the decision-making process.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today applauded the U. S. Preventive Services Task Force (USPSTF) for including computed tomography (CT) colonography in its draft Research Plan on colorectal cancer screening.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today commended the U.S. Preventive Services Task Force (USPSTF) for finalizing its recommendation for the use of annual low-dose computed tomography (LDCT) to screen individuals 55 to 80 years of age who are at high risk for lung cancer. Given the timing of the recommendation, private health plans must cover the imaging service without cost sharing by as early as next year due to an Affordable Care Act (ACA) requirement.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today applauded the Centers for Medicare & Medicaid Services (CMS) for mandating that medical imaging and radiation therapy (RT) equipment in hospitals must be maintained according to the manufacturer’s recommended maintenance standard. MITA said the updated directive to the hospital equipment maintenance guidance will help promote the safety of patients and equipment operators, while also preserving equipment performance and image quality.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today noted progress in the global fight against Alzheimer’s disease (AD) following the announcement at the G8 Dementia Summit that the U.K.’s National Health Service (NHS) will cover beta amyloid positron emission tomography (PET) imaging to rule out AD. It represents the first time beta amyloid PET imaging will be covered as part of a public health system.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today said that Scott Gottlieb’s Wall Street Journal op-ed, This ‘Doc Fix’ Would Be Bad for Your Health, posits a misguided and inaccurate representation of physician-developed appropriateness criteria.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today said that a new study published in the December issue of the American Journal of Roentgenology (AJR) confirms what physicians, researchers and device manufacturers have long known regarding the steady slowdown of Medicare expenditures for medical imaging, while offering new insight into which services are the program’s biggest cost drivers.